Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (2020 - 2025)

Roivant Sciences' Shares Outstanding history spans 6 years, with the latest figure at $709.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding fell 1.38% year-over-year to $709.7 million; the TTM value through Dec 2025 reached $709.7 million, down 1.38%, while the annual FY2025 figure was $695.9 million, 13.73% down from the prior year.
  • Shares Outstanding reached $709.7 million in Q4 2025 per ROIV's latest filing, up from $689.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $806.7 million in Q1 2024 to a low of $651.6 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $720.8 million, with a median of $707.0 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: skyrocketed 3323.95% in 2021, then decreased 13.73% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $692.0 million in 2021, then increased by 5.03% to $726.8 million in 2022, then grew by 10.74% to $804.9 million in 2023, then decreased by 10.59% to $719.6 million in 2024, then dropped by 1.38% to $709.7 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Shares Outstanding are $709.7 million (Q4 2025), $689.7 million (Q3 2025), and $682.2 million (Q2 2025).